Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sernova Corp
T.SVA
Alternate Symbol(s):
SEOVF
Healthcare
Biotechnology
Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch...
System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:SVA)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(2)
•••
MustangSalley
X
View Profile
View Bullboard History
Post by
MustangSalley
on Jun 15, 2022 2:49pm
Trading activity
This is not warrant selling . This is pure manipulation by usual brokerages now. Tsx is no different than Venture exchange. This would not happen on Nasdaq ...... Shame for retail investors
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on Jun 15, 2022 2:39pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
Unfortunately Evotec won't be buying shares at $2.50 on the open market. They will be issued shares. Perhaps they overpaid. Only time will tell. I am still bullish on Sernova's longer term
...more
Fintech Select LTD. Publishes Results for Fiscal Year 2023
posted May 01, 2024 9:00am by
Fintech Select Ltd.
-
|
Under the leadership of Fintech Select's management, the Company achieved a significant milestone in revenue generation, reaching $3,822,182 for fiscal year 2023, compared to $2,587,867 in 2022. Management is confident this 47% increase on a year-over-year basis ...read more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Post by
Metalsguy1
on Jun 15, 2022 2:00pm
New CEO and Chairman needed
If Spillup and Frank had an ounce of integrity they would announce their resignations and a search for a new CEO. Spill needs to go back to the lab.
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Jun 15, 2022 1:56pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
When your selling your commons to exercise warrants at under $1 while Evotec is buying in Aug at $2.50 I would call that a discount. Another thing to consider is sure there are 25 mil
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Comment by
Stockfshr
on Jun 15, 2022 1:46pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
Redbaron: You said "Most in those placements were high net worth individuals they are not going to be forced into a corner selling at a discount to execrise their warrants." Sell at a
...more
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Jun 15, 2022 12:51pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
Not everyone needs to sell commons to exercises their warrants. I'm still sitting on commons that I exercised last year with cash from another deal. Most in those placements were high net
...more
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Jun 15, 2022 12:16pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
Im not saying he planned this end but I do belive the company had invested interest to keep the SP stable around $1.5 until the deal was done. Now that the company is cashed up and the market
...more
(4)
•••
Stockfshr
X
View Profile
View Bullboard History
Post by
Stockfshr
on Jun 15, 2022 12:14pm
Sell-off
I think we are also seeing long term shareholders realizing it could be another couple of years before we have developments positive enough to really move this stock. Meanwhile other diabetes
...more
(137)
•••
MoneyMouth
X
View Profile
View Bullboard History
Comment by
MoneyMouth
on Jun 15, 2022 12:01pm
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
This is going to get really ugly until after September. 25 million shares worth of warrants to be exercised between August 16th and September 2022. This stock cannot handle 25 million in volume
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Comment by
BioTeck
on Jun 15, 2022 11:47am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
You are giving Spill wayyyyyy too much credit to think he planned this or anything. I bet he is angry with the seller(s) instead of being angry with himself for not seeing this coming or his overpaid
...more
(43)
•••
Metalsguy1
X
View Profile
View Bullboard History
Comment by
Metalsguy1
on Jun 15, 2022 11:34am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
Red this is looking more like Spillup flushing the company down the toilet just so he could dance with pride. At least the people whose dumb a$$ response to criticism is " move on" can
...more
(160)
•••
Redbaron2211
X
View Profile
View Bullboard History
Comment by
Redbaron2211
on Jun 15, 2022 11:15am
RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Used BioTech Company For Sale by Owner - 600M OBO.
They will buy at these prices especially when they know the company is cashed up for 3 years. Maybe this was the plan all along. Secure cash then flush out the cheap paper into
...more
(121)
•••
BioTeck
X
View Profile
View Bullboard History
Post by
BioTeck
on Jun 15, 2022 11:12am
.96
Nice work management. Back to .30 cents we go till the warrants expire LOL. What a joke. Evotec has nearly lost 50% on their investment in SVA. They'll be happy about that.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Jun 15, 2022 7:00am
New Press Release - Sernova to Participate in the Truist Securities Cell Therapy Symposium, Symposia-cel in June
LONDON, Ontario, June 15, 2022 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage company and leader in regenerative medicine cell therapeutics, today announced that Dr. Philip Toleikis, President & CEO of Sernova Corp, will be participating in the Truist...
read article.
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project